JP2007106688A5 - - Google Patents

Download PDF

Info

Publication number
JP2007106688A5
JP2007106688A5 JP2005297991A JP2005297991A JP2007106688A5 JP 2007106688 A5 JP2007106688 A5 JP 2007106688A5 JP 2005297991 A JP2005297991 A JP 2005297991A JP 2005297991 A JP2005297991 A JP 2005297991A JP 2007106688 A5 JP2007106688 A5 JP 2007106688A5
Authority
JP
Japan
Prior art keywords
cytokine
related gene
units
expression inhibitor
weight hyaluronan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005297991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007106688A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005297991A priority Critical patent/JP2007106688A/ja
Priority claimed from JP2005297991A external-priority patent/JP2007106688A/ja
Priority to US11/438,819 priority patent/US20070099867A1/en
Priority to AU2006220353A priority patent/AU2006220353A1/en
Priority to RU2006134169/15A priority patent/RU2342148C2/ru
Priority to NO20064337A priority patent/NO20064337L/no
Priority to CA2560844A priority patent/CA2560844C/en
Priority to ARP060104194A priority patent/AR056091A1/es
Priority to BRMU8603015-9U priority patent/BRMU8603015U/pt
Priority to EP06020126A priority patent/EP1767211B1/en
Priority to AT06020126T priority patent/ATE552005T1/de
Publication of JP2007106688A publication Critical patent/JP2007106688A/ja
Publication of JP2007106688A5 publication Critical patent/JP2007106688A5/ja
Pending legal-status Critical Current

Links

JP2005297991A 2005-05-24 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤 Pending JP2007106688A (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2005297991A JP2007106688A (ja) 2005-10-12 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤
US11/438,819 US20070099867A1 (en) 2005-05-24 2006-05-23 Pharmaceutical agent containing hyaluronan as an active ingredient
AU2006220353A AU2006220353A1 (en) 2005-05-24 2006-09-20 Pharmaceutical Agent Containing Hyaluronan as an Active Ingredient
CA2560844A CA2560844C (en) 2005-09-26 2006-09-25 Pharmaceutical agent containing hyaluronan as an active ingredient
NO20064337A NO20064337L (no) 2005-09-26 2006-09-25 Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens
RU2006134169/15A RU2342148C2 (ru) 2005-09-26 2006-09-25 Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента
ARP060104194A AR056091A1 (es) 2005-09-26 2006-09-26 Agente farmaceutico que contiene hialuronano como ingrediente activo
BRMU8603015-9U BRMU8603015U (pt) 2005-09-26 2006-09-26 agente farmacêutico contendo hialuronano como componente ativo
EP06020126A EP1767211B1 (en) 2005-09-26 2006-09-26 Pharmaceutical agent containing hyaluronan as an active ingredient
AT06020126T ATE552005T1 (de) 2005-09-26 2006-09-26 Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005297991A JP2007106688A (ja) 2005-10-12 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤

Publications (2)

Publication Number Publication Date
JP2007106688A JP2007106688A (ja) 2007-04-26
JP2007106688A5 true JP2007106688A5 (el) 2007-11-29

Family

ID=38032837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005297991A Pending JP2007106688A (ja) 2005-05-24 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤

Country Status (1)

Country Link
JP (1) JP2007106688A (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2905610C (en) * 2013-03-14 2021-06-01 Anacoti Ltd. Hyaluronic acid derivatives

Similar Documents

Publication Publication Date Title
JP2008513467A5 (el)
ECSP088240A (es) Composición de trazodona para administración una vez por día
JP2006348039A5 (el)
JP2010047612A5 (el)
IL227934A (en) An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it
JP2012530141A5 (el)
CL2007001132A1 (es) Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
EA200970081A1 (ru) Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
NO20074872L (no) Pyrazoler
EP2279726A3 (en) Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
MX351104B (es) Nuevos glucosaminoglucanos con baja actividad anticoagulante.
JP2007126453A5 (el)
JP2011507976A5 (el)
JP2004525917A5 (el)
JP2007106688A5 (el)
WO2007121545A8 (en) S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions
JP2006335694A5 (el)
JP2006522806A5 (el)
EA200701525A1 (ru) Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением
AR050937A1 (es) Composicion para administracion a traves de la mucosa y metodo para aumentar la absorcion a traves de la mucosa
Chang Humanity, Technology and Environment: A partnership for the Future
AR059678A1 (es) Composicion de trazodona para administracion una vez por dia
高马国 Cheer Up, Little Pig!
Bishimbayeva et al. Approaches to the elaboration of regeneration and transformation systems for elite Kazakh cotton varieties